https://www.selleckchem.com/products/blu9931.html
ral inventions associated to the clinical aspects of SPs for secretory production of recombinant GCSF in E. coli are required for final validation. Breast cancer is one of the most common types among women. Its incidence progressively increases with age, especially after age 50. Platinum compounds are not efficient in the treatment of breast cancer, highlighting the use of other metals for the development of new chemotherapeutic agents.
<p> Objective This paper aims to obtain three new ruthenium compounds that incorporate sulfur amino
Like
Comment
Share
